Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Signaling Switching from Hedgehog-GLI to MAPK Signaling Potentially Serves as a Compensatory Mechanism in Melanoma Cell Lines Resistant to GANT-61.

Autor: Piteša N; Ruđer Bošković Institute, Division of Molecular Medicine, 10 000 Zagreb, Croatia., Kurtović M; Ruđer Bošković Institute, Division of Molecular Medicine, 10 000 Zagreb, Croatia., Bartoniček N; The Garvan Institute of Medical Research, Genome Informatics, Genomics & Epigenetics Division, 384 Victoria St., Darlinghurst, NSW 2010, Australia.; The Kinghorn Centre for Clinical Genomics, 370 Victoria St., Darlinghurst, NSW 2010, Australia., Gkotsi DS; School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK.; Astbury Centre for Molecular Structural Biology, University of Leeds, Leeds LS2 9JT, UK., Čonkaš J; Ruđer Bošković Institute, Division of Molecular Medicine, 10 000 Zagreb, Croatia., Petrić T; Ruđer Bošković Institute, Division of Molecular Medicine, 10 000 Zagreb, Croatia., Musani V; Ruđer Bošković Institute, Division of Molecular Medicine, 10 000 Zagreb, Croatia., Ozretić P; Ruđer Bošković Institute, Division of Molecular Medicine, 10 000 Zagreb, Croatia., Riobo-Del Galdo NA; School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK.; Astbury Centre for Molecular Structural Biology, University of Leeds, Leeds LS2 9JT, UK.; Leeds Institute of Medical Research, Faculty of Medicine and Health, University of Leeds, Leeds LS2 9JT, UK.; Leeds Cancer Research Centre, University of Leeds, Leeds LS2 9JT, UK., Sabol M; Ruđer Bošković Institute, Division of Molecular Medicine, 10 000 Zagreb, Croatia.

Publikováno v: Biomedicines [Biomedicines] 2023 May 03; Vol. 11 (5). Date of Electronic Publication: 2023 May 03.

RNA-seq and ChIP-seq Identification of Unique and Overlapping Targets of GLI Transcription Factors in Melanoma Cell Lines.

Autor: Kurtović M; Division of Molecular Medicine, Ruđer Bošković Institute, 10 000 Zagreb, Croatia., Piteša N; Division of Molecular Medicine, Ruđer Bošković Institute, 10 000 Zagreb, Croatia., Bartoniček N; The Garvan Institute of Medical Research, 384 Victoria St., Darlinghurst, NSW 2010, Australia.; The Kinghorn Centre for Clinical Genomics, 370 Victoria St., Darlinghurst, NSW 2010, Australia., Ozretić P; Division of Molecular Medicine, Ruđer Bošković Institute, 10 000 Zagreb, Croatia., Musani V; Division of Molecular Medicine, Ruđer Bošković Institute, 10 000 Zagreb, Croatia., Čonkaš J; Division of Molecular Medicine, Ruđer Bošković Institute, 10 000 Zagreb, Croatia., Petrić T; Division of Molecular Medicine, Ruđer Bošković Institute, 10 000 Zagreb, Croatia., King C; School of Biotechnology and Biomolecular Sciences, Faculty of Science, University of New South Wales, Sydney, NSW 2052, Australia., Sabol M; Division of Molecular Medicine, Ruđer Bošković Institute, 10 000 Zagreb, Croatia.

Publikováno v: Cancers [Cancers (Basel)] 2022 Sep 19; Vol. 14 (18). Date of Electronic Publication: 2022 Sep 19.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.